Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the ...

The U.S. FDA has approved treatment with Ibtrozi for patients with locally advanced or metastatic ROS1-positive non-small ...

Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with ...

FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.

Two people connect by sharing their experiences about taking care of their spouses who died from cancer, and the realization ...

Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative ...

Patients can prepare for self-advocacy by bringing personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner.